Literature DB >> 32206607

Hereditary causes of primary aldosteronism and other disorders of apparent excess mineralocorticoid activity.

Xin He1, Zubin Modi2,3, Tobias Else1.   

Abstract

Secondary hypertension is a common condition with a broad differential diagnosis. Identification of the true cause of hypertension can be critical for guiding appropriate management. Here, we review hereditary conditions underlying the most common cause of secondary hypertension, primary aldosteronism, as well as other disorders impacting various levels of mineralocorticoid action. Recently, several pathogenic variants of ion channels have been described as etiologies of familial aldosteronism. Defects in steroid hormone synthesis cause hypertension in 11β-hydroxylase deficiency and 17α-hydroxylase deficiency, two types of congenital adrenal hyperplasia. Inappropriate activation of mineralocorticoid receptors underlies the syndrome of apparent mineralocorticoid excess and constitutive activation of the mineralocorticoid receptor. Finally, Liddle syndrome and pseudohypoaldosteronism type 2 are disorders impacting the function of renal sodium channels, the endpoint of mineralocorticoid action. We discuss the pathophysiology, clinical presentation, diagnosis and management of these low renin hypertension states that ultimately result in apparent excess mineralocorticoid activity. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  11β-hydroxylase deficiency; 17α-hydroxylase deficiency; Familial aldosteronism; Liddle syndrome; constitutive activation of the mineralocorticoid receptor; pseudohypoaldosteronism type 2 (PHA2); syndrome of apparent mineralocorticoid excess

Year:  2020        PMID: 32206607      PMCID: PMC7082269          DOI: 10.21037/gs.2019.11.20

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  72 in total

1.  Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.

Authors:  Ute I Scholl; Carol Nelson-Williams; Peng Yue; Roger Grekin; Robert J Wyatt; Michael J Dillon; Robert Couch; Lisa K Hammer; Frances L Harley; Anita Farhi; Wen-Hui Wang; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.

Authors:  R D Gordon; R A Geddes; C G Pawsey; M W O'Halloran
Journal:  Australas Ann Med       Date:  1970-11

3.  Liddle's syndrome, an uncommon form of hyporeninemic hypoaldosteronism: functional and histopathological studies.

Authors:  T Nakada; H Koike; T Akiya; T Katayama; S Kawamata; K Takaya; H Shigematsu
Journal:  J Urol       Date:  1987-04       Impact factor: 7.450

4.  Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule.

Authors:  M Botero-Velez; J J Curtis; D G Warnock
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

5.  CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.

Authors:  S Geley; K Kapelari; K Jöhrer; M Peter; J Glatzl; H Vierhapper; S Schwarz; A Helmberg; W G Sippell; P C White; R Kofler
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

6.  Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2.

Authors:  D B Simon; F E Karet; J M Hamdan; A DiPietro; S A Sanjad; R P Lifton
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

7.  Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.

Authors:  M Stowasser; R D Gordon; T J Tunny; S A Klemm; W L Finn; A L Krek
Journal:  Clin Exp Pharmacol Physiol       Date:  1992-05       Impact factor: 2.557

8.  Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.

Authors:  Amalia Sertedaki; Athina Markou; Dimitrios Vlachakis; Sophia Kossida; Emilie Campanac; Dax A Hoffman; Maria De La Luz Sierra; Paraskevi Xekouki; Constantine A Stratakis; Gregory Kaltsas; George P Piaditis; George P Chrousos; Evangelia Charmandari
Journal:  Clin Endocrinol (Oxf)       Date:  2016-07-12       Impact factor: 3.478

9.  Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel.

Authors:  R A Shimkets; D G Warnock; C M Bositis; C Nelson-Williams; J H Hansson; M Schambelan; J R Gill; S Ulick; R V Milora; J W Findling
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

10.  CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.

Authors:  Georgios Daniil; Fabio L Fernandes-Rosa; Jean Chemin; Iulia Blesneac; Jacques Beltrand; Michel Polak; Xavier Jeunemaitre; Sheerazed Boulkroun; Laurence Amar; Tim M Strom; Philippe Lory; Maria-Christina Zennaro
Journal:  EBioMedicine       Date:  2016-10-04       Impact factor: 8.143

View more
  2 in total

1.  Hypokalemia and hypertensive urgency in a 10-year-old boy: Answers.

Authors:  Ozlem Yuksel Aksoy; Funda Bastug; Binnaz Celik; Salih Uytun
Journal:  Pediatr Nephrol       Date:  2021-04-06       Impact factor: 3.714

2.  Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride-Induced Toxicity.

Authors:  Ademola Adetokunbo Oyagbemi; Olumuyiwa Abiola Adejumobi; Theophilus Aghogho Jarikre; Olumide Samuel Ajani; Ebunoluwa Racheal Asenuga; Idayat Titilayo Gbadamosi; Aduragbenro Deborah A Adedapo; Abimbola Obemisola Aro; Blessing Seun Ogunpolu; Fasilat Oluwakemi Hassan; Olufunke Olubunmi Falayi; Iyanuoluwa Omolola Ogunmiluyi; Temidayo Olutayo Omobowale; Oluwatosin Adetola Arojojoye; Olufunke Eunice Ola-Davies; Adebowale Benard Saba; Adeolu Alex Adedapo; Benjamin Obukowho Emikpe; Matthew Olugbenga Oyeyemi; Sanah Malomile Nkadimeng; Lyndy Joy McGaw; Prudence Ngalula Kayoka-Kabongo; Oluwafemi Omoniyi Oguntibeju; Momoh Audu Yakubu
Journal:  Biol Trace Elem Res       Date:  2021-04-24       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.